EMA – Event: 28 November 2024 - Fifth EMA/HMA Big Data Stakeholder Forum
Event summary As the journey towards data-driven medicines regulation continues, a new phase for the regulatory network is starting. The value of real-world data for evidence generation is becoming more established and technological advances, e.g. in the area of artificial intelligence (AI), have occurred more rapidly than originally anticipated. At the same time, the EU Network is accelerating its efforts to strengthen data governance, to share more data across the Network and to foster hig...
Publication Details
- Journal
- Industrias Culturais (Universidade de Coimbra)
- Published
- 2024-10-19
- DOI
- https://doi.org/10.58079/12jad
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00